Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pooled Allogenic Olfactory Mucosa MSCs in SLE
NCT04184258Phase 2Completed
- Start
- Jul 2019
- Primary completion
- Dec 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogenic pooled olfactory mucosa-derived mesenchymal stem cells in systemic lupus erythematosus (SLE). Started Jul 2019; status: completed.
02
Drugs
allogenic pooled olfactory mucosa-derived mesenchymal stem cells
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT04184258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04184258.